Fresh Rounds

CytoDyn Inc. funding

CytoDyn Inc., a pharmaceuticals company based in Vancouver, WA, filed a Form D with the SEC on May 11, 2026 and reported $18.6M raised.

Amount raised$18.6M
Offering size$18.6M
Filed with the SECMay 11, 2026
First saleJanuary 30, 2026
IndustryPharmaceuticals
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationVancouver, WA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far194
Minimum investment$15K
Revenue rangeDecline to Disclose

Other health care rounds in Washington